GlobeNewswire Inc.··Portnoy Law FirmSoleno Therapeutics Faces Class Action Over Undisclosed Drug Safety Risks
Portnoy Law Firm launches class action against $SLNO for allegedly concealing safety issues with lead drug DCCR, citing 27% stock plunge following patient death disclosure.
SLNOsecurities fraudclass action lawsuit